Pyxis Oncology, Inc. Quarterly Cost of Revenue in USD for Q1 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: Pyxis Oncology, Inc. quarterly Cost of Revenue history and growth rate for Q1 2024.
Pyxis Oncology, Inc. Cost of Revenue for the quarter ending March 31, 2024 was $475K.

Cost of Revenue, Quarterly (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024		$475K			Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.